Adenosylmethionine decarboxylase 1 pseudogene 4 (AMD1P4)

Adenosylmethionine decarboxylase 1 pseudogene 4 (AMD1P4) is classified as a pseudogene, meaning it is a **nonfunctional genomic sequence** that closely resembles the functional gene for adenosylmethionine decarboxylase 1 but does not encode an active protein product. While some pseudogenes have been found to play regulatory roles (e.g., acting as competitive endogenous RNAs or influencing gene expression), there is currently **no evidence that AMD1P4 is a validated therapeutic target, drug target, or key biomarker** in disease. Pseudogenes like AMD1P4 may be transcribed in a tissue-specific manner, but are not generally considered enzymes, receptors, or other therapeutic target classes. Their functions, if any, are most often regulatory rather than catalytic or signaling[1][2][3][4][5]. Key points: - This gene is a **pseudogene**, not a functional protein-coding gene[1][5]. - There is **no evidence it is a therapeutic target** (such as an enzyme or a receptor as implied by the query)[1][3]. - Pseudogenes may sometimes regulate other genes via noncoding RNA mechanisms, but there is **no specific evidence for a disease role or drug interaction for AMD1P4**[2][3][4]. - The information provided points to a nonfunctional or regulatory RNA and **not a target for drugs or direct disease involvement**[1][5]. If a canonical, targetable protein or receptor was intended, the query appears to refer to an incorrect or non-target entity.

Other names

AMD1P4